Compounded medications contain the same active pharmaceutical ingredient as the FDA-approved brand-name drugs (Wegovy, Ozempic, Zepbound, Mounjaro), but the compounded versions themselves are not FDA-approved as finished products and have not been individually evaluated by the FDA for safety, efficacy, or quality
Liraglutide has also been shown to significantly reduce overall energy intake and the consumption of all macronutrients, including carbohydrates, protein, and fat during controlled buffet settings (Quast et al., 2021)
4.8 stars across 4,147 reviews with specific, detailed customer service praise
As Fillit noted, GLP-1 drugs would be very good candidates to be delivered in combination with an anti-amyloid drug like Eisai and Biogens recently approved Leqembi (lecanemab) or Lillys investigational donanemab, because there is no overlap in the mechanism of action
"Market sizing for GLP-1 expanded indications." [30] Eli Lilly